No âmbito do Congresso da ESC 2022, em Barcelona, o simpósio –“How could factor eleven FXI inhibitors help your patients?...
A sessão “The beginning of the end for NOACs? The extra mile”, promovida pela Bayer, no congresso da ESC 2022,...
“Time to act: what if your patient is in need of a different strategy following a worsening heart failure event?”...
No âmbito do ESC Congress 2022, a Bayer promoveu um simpósio satélite intitulado “Time to act: How can we improve...
